State guide · PA · prices checked Oct 3, 2026

GLP-1 in Pennsylvania: prices and Medicaid coverage

As of Oct 3, 2026, the cheapest GLP-1 program that ships to Pennsylvania is SnagRx at $69 a month, month to month, all in; 17 of the 21 partner programs we track ship there. Pennsylvania Medicaid did not cover GLP-1s for weight loss as of January 2026, according to KFF, though it must cover them for type 2 diabetes.

Julian CaraulaniFounder, PriceTracker GLP-1Prices verified October 2026

Cheapest that ships to Pennsylvania

$69/mo

at SnagRx, month to month, all in.

Pennsylvania Medicaid, weight loss

Not covered for weight loss

As of January 2026, per KFF. Diabetes: covered in every state.

$69/mo at SnagRx on SnagRx’s site ↗See all 17 that ship to Pennsylvania

On this page

Programs that ship to Pennsylvania
Does Pennsylvania Medicaid cover it?
Pennsylvania Medicaid in numbers
Medicare in every state
Neighbouring states
Common questions
Sources

Which GLP-1 programs ship to Pennsylvania?

17 of the 21 partner programs we track ship to Pennsylvania, from $69 a month, month to month at SnagRx to $299 at Willow, all in.

Cheapest first by what leaves your account each month, membership fees included, then the shorter plan. Each is a telehealth program: a clinician licensed in Pennsylvania reviews you online and a pharmacy mails the medication. Prices checked Oct 3, 2026.

Show all 17

State list not verified · These say how many states they serve but not which, so we cannot say whether they ship here: bmiMD (48 states), DudeMeds (46 states), TMates (45 states), SkinnyRx (48 states).

Program links pay us a commission. The order is the all-in monthly price, never what anyone pays us. How we earn.

Cheapest GLP-1 nationally Cheapest semaglutide Cheapest tirzepatide Compare every state

Does Pennsylvania Medicaid cover GLP-1s for weight loss?

Not covered for weight loss

Pennsylvania Medicaid did not cover GLP-1s for weight loss as of January 2026, according to KFF, though it must cover them for type 2 diabetes.

Pennsylvania covered GLP-1s for obesity in October 2025 and had ended that coverage by January 2026.

Pennsylvania Medicaid covers one or more older weight-loss drugs, but no GLP-1.

Weight loss

Not covered, January 2026

Type 2 diabetes

Required in every state

Heart risk, sleep apnea

Required (Wegovy, Zepbound)

Prior authorization

Typical when covered

Federal law lets each state decide whether Medicaid pays for drugs used for weight loss, while drugs approved for diabetes must be covered. KFF counts coverage under fee-for-service; if your Pennsylvania Medicaid coverage comes through a managed care plan, its formulary can differ, so ask the plan before you fill.

What may have changed since January

CMS’s BALANCE model lets state Medicaid programs add GLP-1s for weight management at a negotiated price. States could join on a rolling basis from May 1, 2026 through January 1, 2027, and the state application deadline was July 31, 2026. We could not find a published list of the states that joined, so this page does not say whether Pennsylvania Medicaid did. Ask your plan. Either way your cost stays at Medicaid’s nominal copay, which BALANCE does not change.

The national picture, coupons and patient assistance: does Medicaid cover GLP-1s.

How many GLP-1s does Pennsylvania Medicaid pay for?

843,743 GLP-1 prescriptions in 2025, 2nd of the 50 states and DC, with $930.3 million reimbursed before rebates.

Prescriptions, 2025

843,743

2nd of 51

Medicaid paid

$930.3M

2nd of 51, before rebates

Per prescription

$1,103

$1,051 nationally

Weight-loss brands

54%

8th highest share of 51

Wegovy, Zepbound and Saxenda, the brands approved for weight management, were 54% of Pennsylvania Medicaid's GLP-1 prescriptions in 2025 (456,134). Across the 13 states KFF lists as covering GLP-1s for obesity, the median share was 52%; across the other 38, 2.3%. Where weight loss is not covered, those brands are mostly filled for the uses Medicaid must cover, such as heart risk and sleep apnea.

Pennsylvania Medicaid GLP-1 prescriptions by brand, 2025
Brand	Prescriptions	Share	Medicaid paid
Wegovyapproved for weight management	247,331	29%	$324.6 million
Ozempic	234,746	28%	$235.3 million
Zepboundapproved for weight management	207,261	25%	$218.2 million
Trulicity	110,864	13%	$111.1 million
Mounjaro	35,982	4.3%	$34.3 million
Rybelsus	2,991	0.4%	$3.0 million

Source: CMS State Drug Utilization Data 2025, updated Jul 13, 2026, all four quarters, fee-for-service and managed care. Before rebates. CMS suppresses rows under 11 prescriptions, so small brands are undercounted slightly. Every state ranked: prescriptions and spending.

On Medicare in Pennsylvania?

Medicare’s temporary GLP-1 Bridge works the same in every state: a $50 copay for a one-month supply of Wegovy, Foundayo or the Zepbound KwikPen, for people with Part D who meet its weight and health rules.

medicare.gov, read Oct 3, 2026: “You’ll pay a $50 copayment to the pharmacy for a one-month supply (either 28 or 30 days, depending on drug).”

Check the Bridge rules Does Medicare cover GLP-1s?

Pennsylvania and the states around it

Medicaid’s weight-loss answer (January 2026, KFF) and the partner programs that ship there, priced the same way as above.

State	Medicaid, weight loss	Ship there	Cheapest that ships there
Pennsylvania	Not covered	17	$69/mo
Delaware	Covered	17	$69/moSnagRx
Maryland	Not covered	17	$69/moSnagRx
New Jersey	Not covered	17	$69/moSnagRx
New York	Not covered	17	$69/moSnagRx
Ohio	Not covered	17	$69/moSnagRx
West Virginia	Not covered	16	$69/moSnagRx

All 50 states and DC

GLP-1s in Pennsylvania: common questions

Does Pennsylvania Medicaid cover Wegovy or Zepbound for weight loss?

Not as of January 2026: KFF found Pennsylvania Medicaid did not cover GLP-1s for obesity under fee-for-service. Pennsylvania covered GLP-1s for obesity in October 2025 and had ended that coverage by January 2026. Pennsylvania Medicaid covers one or more older weight-loss drugs, but no GLP-1. Coverage for weight loss is optional for each state, so it can change; ask your plan, and see whether Pennsylvania has joined the BALANCE model.

Does Pennsylvania Medicaid cover Ozempic or Mounjaro for diabetes?

Yes. Weight-loss coverage is optional for states, but Medicaid must cover GLP-1s approved for type 2 diabetes, so Ozempic, Mounjaro and the others are covered for blood sugar in Pennsylvania as in every state, usually behind prior authorization. Wegovy for heart risk and Zepbound for sleep apnea are required uses too (KFF).

Has Pennsylvania Medicaid joined the BALANCE model?

We could not find a published list of the state Medicaid programs taking part, so we cannot say. BALANCE is a voluntary CMS model: states could join on a rolling basis from May 1, 2026 through January 1, 2027, and the state application deadline was July 31, 2026 (KFF). It does not change what you pay, because federal law already limits Medicaid out-of-pocket costs to nominal amounts. Ask Pennsylvania Medicaid whether it joined.

What is the cheapest GLP-1 program that ships to Pennsylvania?

SnagRx, at $69 a month, month to month all in (membership included), checked Oct 8, 2026. Then Embody at $69 on a 12-month plan, and CoreAge Rx at $99, month to month. These are telehealth programs: a clinician licensed in Pennsylvania reviews you online and a pharmacy mails the medication.

How many GLP-1 telehealth programs ship to Pennsylvania?

17 of the 21 partner programs we track ship to Pennsylvania on a state list we could verify. None of them names Pennsylvania as a state it does not serve. 4 publish a state count without the list, so we cannot say: bmiMD, DudeMeds, TMates, SkinnyRx.

How many GLP-1 prescriptions did Pennsylvania Medicaid pay for in 2025?

843,743, 2nd of the 50 states and DC, with $930.3 million reimbursed before rebates (CMS State Drug Utilization Data). Wegovy, Zepbound and Saxenda, the brands approved for weight management, were 54% of those prescriptions.

Can I get a GLP-1 for $50 a month on Medicare in Pennsylvania?

If you have Medicare Part D and meet the rules, yes. Medicare's temporary GLP-1 Bridge is the same in every state: medicare.gov says "This temporary program is available nationwide (including all states and U.S. territories) to certain people with Medicare drug coverage (Part D)" and "You’ll pay a $50 copayment to the pharmacy for a one-month supply (either 28 or 30 days, depending on drug)." (read Oct 3, 2026).

Sources

Program prices are read off each seller’s own page weekly; the last check behind this page was Oct 3, 2026. The Medicaid answer is KFF’s, quoted below with the day we read it, and is re-read monthly. The prescription figures are CMS’s.

KFF state map, the Pennsylvania row

“Pennsylvania,PA*,Not covered”

https://datawrapper.dwcdn.net/GL0OB/8/dataset.csv · read Oct 8, 2026

KFF, published Jan 16, 2026

“13 state Medicaid programs covering GLP-1s for obesity treatment under FFS as of January 2026”